SOURCE: Milestone Scientific, Inc.

Milestone Scientific, Inc.

March 30, 2016 16:05 ET

Milestone Scientific Announces Plan to Reschedule 2015 Earnings Conference Call

LIVINGSTON, NJ--(Marketwired - March 30, 2016) - Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it will reschedule the 2015 year-end conference call originally planned for March 31, 2016. 

The Company has filed with the U.S. Securities and Exchange Commission a Form 12b-25 requesting an extension to timely file its Annual Report on Form 10-K for the year ended December 31, 2015 and allow it to complete its financial statements and related disclosures related to the Company's minority-owned Epidural & Intra-Articular Subsidiary.

The Company plans to announce a new date and time for the year-end conference call as soon as practical and expects to file its Annual Report on Form 10-K within the 15-day extension period afforded by Rule 12b-25.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com.

Contact Information

  • Contact:
    David Waldman or Natalya Rudman
    Crescendo Communications, LLC
    Email: mlss@crescendo-ir.com
    Tel: 212-671-1020